Therapy: Risks associated with chronic PPI use — signal or noise?

@article{Kia2016TherapyRA,
  title={Therapy: Risks associated with chronic PPI use — signal or noise?},
  author={L. Kia and P. Kahrilas},
  journal={Nature Reviews Gastroenterology &Hepatology},
  year={2016},
  volume={13},
  pages={253-254}
}
Chronic kidney disease has joined the growing list (pneumonia, myocardial infarction, hip fracture, Clostridium difficile infections, acute interstitial nephritis, hypomagnesaemia) of putative risks associated with chronic PPI use based on results from an observational epidemiological study. However, the low hazard ratio (<1.5) makes it doubtful that this association is a causal relationship. 
View on Nature
zenodo.org
19 Citations
Background Citations
2
Results Citations
1

Tables and Topics from this paper

19 Citations

Citation Type

Citation Type

Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?
  • 10
When is proton pump inhibitor use appropriate?
  • 41
Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe
  • 24
  • PDF
Abnormal esophageal acid exposure on high‐dose proton pump inhibitor therapy is common in systemic sclerosis patients
  • E. Stern, D. Carlson, +5 authors D. Brenner
  • Medicine
  • Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2018
  • 8
Potential proton pump inhibitor–related adverse effects
  • 2
Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden
  • 7
  • PDF
Potential Adverse Drug Events and Nephrotoxicity Related to Prophylaxis With Omeprazole for Digestive Disorders: A Prospective Cohort Study.
  • 2
  • PDF
Comparative Study of Spontaneous Bacterial Peritonitis in Cirrhosis Patients Managed with and without Proton Pump Inhibitors
  • 1
  • PDF
ACG and CAG Clinical Guideline: Management of Dyspepsia
  • 204
Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease
  • 6
  • PDF
...
1
2
...

References

SHOWING 1-10 OF 13 REFERENCES
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
  • 239
  • PDF
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
  • 384
  • PDF
Proton pump inhibitors and acute kidney injury: a nested case–control study
  • 70
  • PDF
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
  • 350
  • PDF
Long-term proton pump inhibitor therapy and risk of hip fracture.
  • 1,081
  • PDF
Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe
  • 24
  • PDF
Abnormal esophageal acid exposure on high‐dose proton pump inhibitor therapy is common in systemic sclerosis patients
  • E. Stern, D. Carlson, +5 authors D. Brenner
  • Medicine
  • Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2018
  • 8
Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
  • 22
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
  • 194
  • PDF
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use
  • 126
  • PDF
...
1
2
...